Olaparib and durvalumab in patients with relapsed small cell lung cancer (MEDIOLA): An open-label, multicenter, phase 1/2, basket study - Concepedia

Concepedia

Publication | Open Access

Olaparib and durvalumab in patients with relapsed small cell lung cancer (MEDIOLA): An open-label, multicenter, phase 1/2, basket study

DOI Full Paper Access

36

Citations

28

References

2023

Year

Matthew Krebs, Jean‐Pierre Delord, T.R. Jeffry Evans, Maja J.A. de Jonge, Sang‐We Kim, Marie Meurer, Sophie Postel‐Vinay, Jong Seok Lee, Helen K. Angell, Vidalba Rocher-Ros,

References

	Year	Citations

Page 1